location:
 
Home >> About ACEA >> News Releases
 
News Releases
 
10 June 2010
Reducing Animal Testing: Real-time Cell Analysis with Roche´s xCELLigence System for the Early Detection of Hepatic Cytotoxicity
>>Read the whole article
 
8 June 2010
University of Maryland Researchers Use Roche´s xCELLigence System to Study Role of "Microtentacles" on Breast Tumor Cells in Spread of Cancer
>>Read the whole article
 
29 April 2010
Measurement of Compound-Induced Cytotoxicity with Roche’s xCELLigence Real-Time Cell Analysis System
>>Read the whole article
 
28 April 2010
The 2rd Alberta-Zhejiang Life Sciences Forum - Innovative Cell-Based Technologies in Public Health
>>Read the whole article
 
7 December 2009
ACEA Biosciences, Inc. Announces New Patent; Broad Claims Granted for chemical compounds with anti-cancer properties.
>>Read the whole article
 
25 November
Inhibition of Cell Migration by Gene Silencing - Measured with the xCELLigence Cell Analysis System from.
>>Read the whole article
 
19 November 2009
New integrated testing strategy for the evaluation of environmental contaminants.
>>Read the whole article
 
12 August 2009
ACEA Biosciences, Inc. Announces New Patent; Broad Claims Granted for Devices, Systems, and Methods for assaying cells using cell-substrate impedance monitoring.
>>Read the whole article
 
31 March 2009
Phase I ToxCast Data presented for First Time by the US EPA and EPA Extends ACEA's Participation for the Second Phase
>>Read the whole article
 
7 January 2009
In December, 2008, the United States Patent Office awarded ACEA Biosciences, a pioneer in the development of high-performance microelectronic systems for cell-based assays, three (3) United States patents in the area of real-time, label-free microelectronic technology with broad uses in biomedicine, toxicology, and pharmaceutical development
>>Read the whole article
 
7 July 2008
We are pleased to announce the launch of the xCELLigence System, a cell-based assay system that represents the perfect integration of micro electronics and cell biology.
>>Read the whole article
 
27 June 2008
The use of the xCELLigence System, developed by ACEA Biosciences, Inc. and its worldwide cooperation partner Roche, in a label-free measurement of natural killer (NK) cell cytotoxic activity in real time was recently profiled in the Forbes.com Business Wire. 
>>Read the whole article
 
15 November 2007
Roche and ACEA enter exclusive world-wide agreement. Roche Applied Science acquires innovative key technology for cell-analysis
>>Read the whole article
 
6 July 2007
ACEA Biosciences is profiled in the June 2007 Kalorama Report on " Early Toxicology: Markets and Approaches" as one of the emerging companies for in-vitro toxicity testing.
>>Read the whole article
 
10 April 2007
ACEA Biosciences, Inc. Awarded a ToxCast Contract by U. S. Environmental Protection Agency to Screen and Classify Toxic Environmental Chemicals using its RT-CEStm System.
>>Read the whole article
3 April 2007
United States Patent Office awarded ACEA Biosciences patent for high-performance microelectronic systems for cell-based assays.
1 January 2007
ACEA Biosciences, Inc., is profiled in the January, 2007 issue of Bioscience Technology, on "Biology for the Information Age: Cell Based Assays - Creating High Content from Cells" , which focused on a number of new technologies used in the development of high-content, cell-based assays.
17 November 2006
ACEA Biosciences, Inc., conducted a scientific workshop, "Advanced Cell Electronic Array Workshop" with the Government of Alberta  on the use of RT-CES® System in Environmental Health, Cytotoxicity, Microbiology, and Environmental Toxicology.
15 September 2006
ACEA Biosciences, Inc., is profiled in the issue of Genetic Engineering News, on "Biomolecular Screening Technologies - Better Characterization Is the Key to Finding a Successful Target".